Migraine News

If you happened to miss Part 1 of 2 in this series, click here to see what you've missed so far: [Again, as previously noted, I'll do my best to...

Our world is still changing every day because of COVID-19. Keeping up with all of the news can be challenging. Here are some of the top COVID-19 updates for people...

On March 19, the U.S. Food and Drug Administration (FDA) approved the testing of two drugs, chloroquine (hydroxychloroquine) and remdesivir, to treat people with COVID-19. The drugs have been given...

The United States Food and Drug Administration (US FDA) has just approved Vyepti™ for the preventive treatment of migraine. Vyepti (eptinezumab-jjmr) will be the first intravenous (IV) preventive treatment on...

Want to get more involved in the Migraine & Cluster communities? Here's a list of in-person events for the rest of 20I7. There are events to help raise funds (walk/races...

In addition to pain, sickness, and - for many - daily disability, migraine carries a severe burden of discrimination and negativity from many community members. This is social stigma. History...

The migraine world has been abuzz lately about new drugs in development to prevent migraine attacks. These drugs, called monoclonal antibodies, target an amino acid called CGRP (calcitonin gene-related peptide)...

The American Academy of Neurology released information about a new study this week that addresses the risk of heart attack and stroke for women living with migraine with aura. While...

Migraine.com just celebrated its 2-year anniversary as a community resource for people with migraine. About six months after the site was first launched, we asked you what you thought about...

I just returned from this year’s European Federation of Neurological Sciences meeting where thousands of neurologists from all over the world gather to discuss their latest research. It’s an exciting...